Ashland (ASH) said Tuesday it has completed a $10 million expansion of its pharmaceutical production plant in Cabreuva, Brazil, to meet rising demand for coated tablets in Latin America and Brazil.
As part of the investment, the company has also upgraded its equipment for microbial protection in personal care applications at the research and development laboratory of its technical center in Sao Paulo, Ashland said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.